Antidepressants and the Cytochrome P450 Enzymes

Journal of the American Psychiatric Nurses Association

Volumn 2, Issue 6, 1996, Pages 216-218

  Glod, Carol A ^a,b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750809766     PISSN: 10783903     EISSN: None     Source Type: Journal    
DOI: 10.1177/107839039600200606     Document Type: Article

References (8)

1. Daniel, D. G., Randolph, C., Jaskiw, G., Handel, S., William, T., Abi-Dargham, A., Shoaf, S., Egan, M., Elkashef., A, Liboff, S., & Linnoila, M. (199-4). Coadministration of fluvoxamine increases serum concentrations of haloperidol. Journal of Clinical Psychopbarmacology, 14, 340-343.
2. Hiemke, C., Weigrnann, H., Harter, S., Dahmen, N., Wetzel, H., & Mullet, H. (1994). Elevated levels of clozapine in serum after addition of fluvoxamine. Journal of Clinical Pharmacology, 14, 279-281.
3. Jalil, P. (1992). Toxic reaction following the combined administration of fluoxetine and phenytoin: Two case reports. Journal of Neurology, Neiirostirgery and Psychiatry, 55, 412-413.
4. Jerling, M., Lindstrom, L., Bondesson, U., & Bertilsson, L. (1994). Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: Evidence from a therapeutic drug monitoring service. Therapeutic Drug Monitoring, 16, 368-374.
5. Nemeroff, C. B., DeVane, C. I., & Pollock, B. G. (1996). Newer antidepressants and the cytochrome P450 system. American Journal of Psychiatry, 153, 311-320.
6. Pollock, B. G., Sweet, R. A., Kirshner, M., & Reynolds, C. F. III. Bupropion plasma levels and CYP2D6 phenotype. Therapeutic Drug Monitoring (in press).
7. Shader, R. L, Greenblatt, D. J., & von Moltke, L. L. (1994). Fluoxetine inhibition of phenytoin metabolism. Journal of Clinical Psychopharmacology, 14, 375-376.
8. Vaughn, D. A. (1988). Interaction of fluoxetine with tricyclic antidepressants (letter). American Journal of Psychiatry, 145, 1478.